Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Medical Mycology Case Reports is Scopus-indexed (Q3, CiteScore 2.3), WoS ESCI, DOAJ. Published by Elsevier B.V..
Checked against the index lists dated .
ISSN 2211-7539Verify ISSN ↗
Publisher: Elsevier B.V.
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Infectious Diseases | 234 / 361 | 35th | Q3 |
| Microbiology | 151 / 194 | 22nd | Q4 |
Not listed in: ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2012–present, best quartile Q3, CiteScore 2.3.
Medical Mycology Case Reports is Q3 in Infectious Diseases (rank 234 of 361) and Q4 in Microbiology (rank 151 of 194), by CiteScore 2025.
Medical Mycology Case Reports is indexed in the Emerging Sources Citation Index, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 2.3, which places it in quartile Q3 at the 35th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.377, quartile Q3, with an H-index of 27.
The publisher lists an article processing charge of about US$650 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Medical Mycology Case Reports is published by Elsevier B.V. Its ISSN is 2211-7539.
Yes — indexed in the Emerging Sources Citation Index.
Yes — it is an open-access journal, listed in DOAJ.
Medical Mycology Case Reports has an h-index of 33 and a 2-year mean of 1.12 citations per paper (OpenAlex). Its Scopus CiteScore is 2.3, quartile Q3. On 2-year citations it ranks #226 of 354 Scopus journals in Infectious Diseases.
Medical Mycology Case Reports published 66 papers in 2025; its busiest recent year was 2019 with 75. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 97 research articles (2025–2026), authors are most often from United States (21.4%), China (10.3%) and Thailand (8.8%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 1 retracted paper is recorded (1.2 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.